Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Hollis-Eden Pharmaceuticals, Inc. is developing through its Hormonal Signaling Technology Platform a proprietary new class of small molecule compounds that are metabolites or synthetic analogs of adrenal steroid hormones. These compounds, designed to restore the biological activity of cellular signaling pathways disrupted by disease and aging, have been demonstrated in humans to possess several properties with potential therapeutic benefit – they regulate innate and adaptive immunity, reduce nonproductive inflammation and stimulate cell ( www.holliseden.com )
Hollis-Eden Pharmaceuticals , Inc.
4435 Eastgate Mall Suite 400
San Diego, California 92121
USA
Tel: (858) 587-9333
Fax: (858) 558-6470